Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and rofecoxib

4-butyrolactone has been researched along with rofecoxib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belmont, D; Blazecka, PG; Davidson, JG; Zhang, J1
Knaus, EE; Praveen Rao, PN; Zarghi, A1
Nijmeijer, SM; Ruchirawat, S; van den Berg, M; van Duursen, MB1
Borges, A; Casoti, R; da Cunha, NL; da Rocha Pissurno, AP; da Silva de Laurentiz, R; E Silva, MLA; Kawano, DF1

Other Studies

4 other study(ies) available for 4-butyrolactone and rofecoxib

ArticleYear
Reinvestigation of mucohalic acids, versatile and useful building blocks for highly functionalized alpha,beta-unsaturated gamma-butyrolactones.
    Organic letters, 2002, Dec-12, Volume: 4, Issue:25

    Topics: 4-Butyrolactone; Anti-Inflammatory Agents; Lactones; Molecular Structure; Sulfones

2002
Sulfonamido, azidosulfonyl and N-acetylsulfonamido analogues of rofecoxib: 4-[4-(N-acetylsulfonamido)phenyl]-3-(4-methanesulfonylphenyl)-2(5H)furanone is a potent and selective cyclooxygenase-2 inhibitor.
    Bioorganic & medicinal chemistry letters, 2004, Apr-19, Volume: 14, Issue:8

    Topics: 4-Butyrolactone; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Lactones; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Sulfones

2004
Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells.
    Toxicology letters, 2010, Feb-15, Volume: 192, Issue:3

    Topics: 4-Butyrolactone; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Cell Cycle; Cell Line, Tumor; Enzyme Induction; Flavonoids; Gene Expression; Humans; Lactones; Lignans; Mitogen-Activated Protein Kinase Kinases; Neoplasms, Hormone-Dependent; Phytoestrogens; Protein Processing, Post-Translational; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship; Sulfones

2010
COX Inhibition Profiles and Molecular Docking Studies of the Lignan Hinokinin and Some Synthetic Derivatives.
    Molecular informatics, 2018, Volume: 37, Issue:12

    Topics: 4-Butyrolactone; Benzodioxoles; Binding Sites; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Humans; Lactones; Lignans; Meloxicam; Molecular Docking Simulation; Protein Binding; Quantitative Structure-Activity Relationship; Substrate Specificity; Sulfones

2018